Figure 2.

In silico analysis of overall survival and progression-free survival. A. Kaplan-Meier analysis of the overall survival rate of patients expressing NOX4 (P = 0.000). B. Kaplan-Meier analysis of the progression-free survival rate of patients expressing NOX4 (P = 0.000).